FDA Grants Octapharma 7-Year Market Exclusivity for Octagam 10%
FDA Approves IVIG to Treat Adults with Dermatomyositis
AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors
14 Rheumatology Treatments Make Top 50 List of Drugs That Can Cause Anaphylaxis
FDA Approves Tocilizumab to Treat Systemic Sclerosis-Associated ILD
FDA Approves Belimumab & Voclosporin for Lupus Nephritis
Health Canada Approves CT-P13 SC for RA; Plus Tofacitinib May Increase Cardiac & Cancer Risks
FDA Approves New Rituximab Biosimilar & Anakinra to Treat a Rare Disease
FDA Provides 2020 Rheumatology Drug Update
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 27
- Next Page »